COMMUNIQUÉS West-GlobeNewswire

Orion Corporation: Acquisition of own shares during week 37, 2026
11/09/2026
Orion Corporation: Acquisition of own shares during week 37, 2026 The share buybacks form part of the share buyback programme that Orion Corporation announced on 27 August 2026. The buyback programme runs from 1 [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT 2026
11/09/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Sanofi: Information concerning the total number of voting rights and shares - August 2026
11/09/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Outlook Therapeutics Fireside Chat from H.C. Wainwright Conference Now Available On-Demand
11/09/2026
Fireside chat featuring Bob Jahr, Chief Executive Officer, and H.C. Wainwright Managing Director & Senior Biotechnology Equity Research Analyst Access the video webcast here ISELIN, N.J., Sept. 11, 2026 (GLOBE [...]
Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting for PMX PMA
11/09/2026
• Company gains further clarity on the additional information required to advance its PMA review • FDA did not request an additional clinical trial following its 100-day review of the PMA application • Company does not [...]
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
11/09/2026
HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared TMS Robotic System; the HOPE clinical team is completing orientation and training at Zeta Surgical's headquarters in Boston [...]
Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
11/09/2026
WILMINGTON, Del., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the H.C [...]
ALK to present at the Morgan Stanley Global Healthcare Conference in New York
11/09/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that the company’s Executive Vice President and CFO, Claus Steensen Sølje, is scheduled to participate in a fireside chat at the Morgan Stanley 24th Annual Global [...]
Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)
11/09/2026
Future registration-directed clinical development of efti is intended to focus on head and neck squamous cell carcinoma (HNSCC) in patients with negative PD-L1 expression (Combined Positive Score (CPS) < 1) and the [...]
Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
11/09/2026
Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen [...]
Tempest Therapeutics Announces Up to $7.5 Million Private Placement
11/09/2026
$2.5 million upfront with up to approximately $5 million of potential aggregate gross proceeds upon the exercise in full of warrants BRISBANE, Calif. , Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. ( [...]
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
11/09/2026
SAN FRANCISCO, CALIFORNIA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the [...]
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
11/09/2026
TARPON SPRINGS, Fla., September 11, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated [...]
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
11/09/2026
Access the video webcast here HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that its pre-recorded presentation from the H.C. [...]
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
11/09/2026
NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand [...]
Dental Implant Surgery and Implant Restoration: What Patients Need to Know
11/09/2026
Implant position, depth and angulation are decided during surgery, and the restoration built afterward cannot undo them. Institute for Advanced Dentistry & Implants manages dental implant surgery and implant [...]
Dance Fitness Tempe Announces Expansion of Accessible Digital Movement Programs
11/09/2026
TEMPE, Arizona, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Dance Fitness Tempe today announced the launch of expanded digital dance content and free online workout programs aimed at making movement accessible to its growing [...]
Vystar Enters the Digital Economy Through R3alm Ownership
11/09/2026
Vystar’s 50 percent interest places the public company inside r3alm’s developing 22-module AI, digital-finance and tokenized-asset ecosystem BOSTON, MA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- R3alm and Vystar Corporation ( [...]
MemoVolt Launch 2026: New Natural Dual-Action Brain and Memory Support Formula Read MemoVolt Brain Supplement Facts & Ingredients Highlights.
11/09/2026
MemoVolt Launch 2026 introduces a natural dual-action brain and memory support formula. Explore MemoVolt Brain Supplement facts, ingredients, and key formulation highlights. New York, Sept. 11, 2026 (GLOBE NEWSWIRE) -- [...]

Pages